Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
1.
Pneumologie ; 72(5): 347-392, 2018 May.
Artigo em Alemão | MEDLINE | ID: mdl-29758578

RESUMO

Cystic Fibrosis (CF) is the most common autosomal-recessive genetic disease affecting approximately 8000 people in Germany. The disease is caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene leading to dysfunction of CFTR, a transmembrane chloride channel. This defect causes insufficient hydration of the epithelial lining fluid which leads to chronic inflammation of the airways. Recurrent infections of the airways as well as pulmonary exacerbations aggravate chronic inflammation, lead to pulmonary fibrosis and tissue destruction up to global respiratory insufficiency, which is responsible for the mortality in over 90 % of patients. The main aim of pulmonary treatment in CF is to reduce pulmonary inflammation and chronic infection. Pseudomonas aeruginosa (Pa) is the most relevant pathogen in the course of CF lung disease. Colonization and chronic infection are leading to additional loss of pulmonary function. There are many possibilities to treat Pa-infection. This is a S3-clinical guideline which implements a definition for chronic Pa-infection and demonstrates evidence-based diagnostic methods and medical treatment for Pa-infection in order to give guidance for individual treatment options.


Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/genética , Fibrose Cística/diagnóstico , Fibrose Cística/terapia , Guias de Prática Clínica como Assunto , Pseudomonas aeruginosa/isolamento & purificação , Fibrose Cística/complicações , Fibrose Cística/microbiologia , Regulador de Condutância Transmembrana em Fibrose Cística/metabolismo , Alemanha , Humanos , Infecções por Pseudomonas/diagnóstico
2.
Infection ; 42(1): 15-21, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24166131

RESUMO

PURPOSE: Two endoscopy-associated nosocomial outbreaks caused by carbapenemase-producing Klebsiella pneumoniae (CPKP) were recently observed in two German hospitals. In this study, we performed a systematic search of the medical literature in order to elucidate the epidemiology of Klebsiella spp. in endoscopy-associated outbreaks. METHODS: Medline, the Outbreak Database ( http://www.outbreak-database.com ) and reference lists of articles extracted from these databases were screened for descriptions of endoscopy-associated nosocomial outbreaks. The data extracted and analysed were: (1) the type of medical department affected; (2) characterisation of pathogen to species and conspicuous resistance patterns (if applicable); (3) type of endoscope and the grade of its contamination; (4) number and the types of infections; (5) actual cause of the outbreak. RESULTS: A total of seven nosocomial outbreaks were identified, of which six were outbreaks of endoscopic retrograde cholangiopancreatography-related infections and caused by contaminated duodenoscopes. Including our own outbreaks in the analysis, we identified one extended-spectrum beta-lactamase-producing K. pneumoniae strain and six CPKP strains. Insufficient reprocessing after the use of the endoscope was the main reason for subsequent pathogen transmission. CONCLUSIONS: There were only two reports of nosocomial outbreaks due to Klebsiella spp. in the first three decades of endoscopic procedures, but seven additional outbreaks of this kind have been reported within the last 4 years. It is very likely that many of such outbreaks have been missed in the past because this pathogen belongs to the physiological gut flora. However, with the emergence of highly resistant (carbapenemase-producing) strains, strict adherence to infection control guidelines is more important than ever.


Assuntos
Colangiopancreatografia Retrógrada Endoscópica/efeitos adversos , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/microbiologia , Surtos de Doenças , Infecções por Klebsiella/epidemiologia , Infecções por Klebsiella/microbiologia , Klebsiella pneumoniae/isolamento & purificação , Descontaminação , Desinfecção , Endoscópios/microbiologia , Humanos , Klebsiella pneumoniae/enzimologia , Prevalência , beta-Lactamases/metabolismo
3.
Zentralbl Chir ; 136(1): 74-8, 2011 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-21337294

RESUMO

BACKGROUND: So-called polyphasic nosocomial outbreaks describe a situation in which additional infections occur after a certain case-free interval - despite the detection of the outbreak's source. This article summarises the results of a systematic search of the medical literature on polyphasic outbreaks. MATERIALS AND METHODS: For this purpose, the Outbreak Worldwide-Database, PubMed and reference lists of relevant articles were screened. RESULTS: A total of 124 polyphasic outbreaks (median duration of 50 weeks) was included in the analysis and then compared to 2089 monophasic nosocomial outbreaks. Surgical departments were significantly more often involved in polyphasic outbreaks than they were in monophasic events (33.9 % vs. 24.5 %; p < 0.05). Hepatitis B virus outbreaks were significantly more often seen as poly-phasic events. Either there had been more than one source initially, or a new source developed during the first phase of the outbreak and led to additional cases thereafter. CONCLUSIONS: Up to now, only little is known about polyphasic nosocomial outbreaks. Thus, there is a further need to close this gap of information in the future. Personnel on the ward as well as -infection control staff should always consider the possibility of the existence of more than one -source when investigating a nosocomial outbreak.


Assuntos
Infecção Hospitalar/epidemiologia , Surtos de Doenças/estatística & dados numéricos , Centro Cirúrgico Hospitalar/estatística & dados numéricos , Infecções Bacterianas/epidemiologia , Infecções Bacterianas/prevenção & controle , Infecções Bacterianas/transmissão , Portador Sadio , Busca de Comunicante , Infecção Hospitalar/prevenção & controle , Infecção Hospitalar/transmissão , Comparação Transcultural , Estudos Transversais , Surtos de Doenças/prevenção & controle , Inquéritos Epidemiológicos , Hepatite B/epidemiologia , Humanos , Micoses/epidemiologia , Micoses/prevenção & controle , Micoses/transmissão , Garantia da Qualidade dos Cuidados de Saúde , Recidiva , Gestão de Riscos , Viroses/epidemiologia , Viroses/prevenção & controle , Viroses/transmissão
4.
Infection ; 39(1): 29-34, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21153042

RESUMO

Epidemiological findings of a single outbreak event may not be generalized; however, the characteristics of a typical outbreak can be determined on the basis of a large number of similar events. The Outbreak Database ( http://www.outbreak-database.com ) is the largest collection of nosocomial outbreaks currently available-and is still expanding. Articles are filed systematically, enabling those on a specific parameter of interest to be retrieved quickly. As such, this database is an extremely valuable tool on many medically related fronts, such as for educating other medical personnel, providing relevant information during the investigation of an acute outbreak, or addressing scientific-oriented questions. Several systematic reviews on a wide range of subjects, including sources of infections, types of pathogens, routes of transmission, appropriate infection control measures, and patients at risk of infection, have already been published based on information contained in this database. As this database may be used free of charge, all medical staff in the field of infection control, hygiene, and hospital epidemiology should be aware of its existence.


Assuntos
Controle de Doenças Transmissíveis/métodos , Infecção Hospitalar/epidemiologia , Bases de Dados Factuais , Surtos de Doenças , Humanos
6.
J Hosp Infect ; 70(1): 15-20, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18602185

RESUMO

Nosocomial Clostridium difficile-associated disease (CDAD) is a common infection in hospitals. A matched case-control study was carried out to determine hospital-wide excess costs due to CDAD. Cases were assessed by prospective hospital-wide surveillance in a tertiary care university hospital in 2006. Nosocomial cases of CDAD (>72h after admission) were matched to control patients without CDAD in a ratio 1:3 using the same diagnosis-related group in the same year, for a hospital stay at least as long as the time of risk of the CDAD cases before infection and a Charlson comorbidity index +/-1. Data on overall costs per case were provided by the finance department. Matching was possible for 45 nosocomial CDAD cases. The difference in the length of stay showed that CDAD cases stayed significantly longer (median 7 days; P=0.006) than their matched controls. The average cost per CDAD patient was euro 33,840. The difference in the cost per patient showed that the cost for CDAD patients was significantly more than for their matched controls (median euro 7,147; 95% confidence interval: 4,067-9,276). Nosocomial CDAD is associated with high costs for healthcare systems. Clinicians should be aware of the financial impact of this disease and the application of appropriate infection control measures is recommended to reduce spread.


Assuntos
Clostridioides difficile/isolamento & purificação , Efeitos Psicossociais da Doença , Infecção Hospitalar/economia , Diarreia/economia , Enterocolite Pseudomembranosa/economia , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Estudos de Casos e Controles , Diarreia/microbiologia , Enterocolite Pseudomembranosa/microbiologia , Feminino , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos
7.
Clin Microbiol Infect ; 14 Suppl 5: 2-20, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18412710

RESUMO

Clostridium difficile-associated diarrhoea (CDAD) presents mainly as a nosocomial infection, usually after antimicrobial therapy. Many outbreaks have been attributed to C. difficile, some due to a new hyper-virulent strain that may cause more severe disease and a worse patient outcome. As a result of CDAD, large numbers of C. difficile spores may be excreted by affected patients. Spores then survive for months in the environment; they cannot be destroyed by standard alcohol-based hand disinfection, and persist despite usual environmental cleaning agents. All these factors increase the risk of C. difficile transmission. Once CDAD is diagnosed in a patient, immediate implementation of appropriate infection control measures is mandatory in order to prevent further spread within the hospital. The quality and quantity of antibiotic prescribing should be reviewed to minimise the selective pressure for CDAD. This article provides a review of the literature that can be used for evidence-based guidelines to limit the spread of C. difficile. These include early diagnosis of CDAD, surveillance of CDAD cases, education of staff, appropriate use of isolation precautions, hand hygiene, protective clothing, environmental cleaning and cleaning of medical equipment, good antibiotic stewardship, and specific measures during outbreaks. Existing local protocols and practices for the control of C. difficile should be carefully reviewed and modified if necessary.


Assuntos
Clostridioides difficile/crescimento & desenvolvimento , Infecção Hospitalar/prevenção & controle , Enterocolite Pseudomembranosa/prevenção & controle , Controle de Infecções/métodos , Infecção Hospitalar/microbiologia , Diarreia/microbiologia , Diarreia/prevenção & controle , Enterocolite Pseudomembranosa/microbiologia , Medicina Baseada em Evidências , Guias como Assunto , Humanos
8.
Hautarzt ; 59(4): 319-22, 2008 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-17646948

RESUMO

We report cases of immunocompetent patients showing multiple abscesses by a Panton-Valentine leukocidin (PVL) positive Staphylococcus aureus. PVL is considered to be an important virulence factor. The most common manifestations by this pathogen are recurrent or multiple abscesses of the skin. Seldom necrotizing pneumonia with high mortality occurs. Even methicillin-resistant PVL positive isolates have been identified in Germany. Only appropriate infection control measures in combination with antimicrobial therapy resulted in successful eradication of this pathogen. Dermatologists should be informed about this specific type of infection and about the appropriate infection control measures.


Assuntos
Abscesso/microbiologia , Toxinas Bacterianas , Exotoxinas , Leucocidinas , Infecções Cutâneas Estafilocócicas , Staphylococcus aureus/patogenicidade , Abscesso/tratamento farmacológico , Abscesso/prevenção & controle , Adolescente , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Criança , Farmacorresistência Bacteriana , Feminino , Seguimentos , Humanos , Controle de Infecções , Masculino , Meticilina/farmacologia , Resistência a Meticilina , Pneumonia Estafilocócica/etiologia , Recidiva , Estudos Retrospectivos , Infecções Cutâneas Estafilocócicas/diagnóstico , Infecções Cutâneas Estafilocócicas/tratamento farmacológico , Infecções Cutâneas Estafilocócicas/prevenção & controle , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/isolamento & purificação , Fatores de Tempo , Resultado do Tratamento , Virulência
9.
Urologe A ; 47(1): 54-8, 2008 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-18043904

RESUMO

BACKGROUND: We estimated the avoidable costs due to nosocomial urinary tract infections (UTI) based on the data of the German National Nosocomial Infections Surveillance System (KISS). METHODS: The incidence of nosocomial UTI derived from KISS reference data. The overall number of patient days was obtained from the "Statistische Bundesamt" (German Federal Office of Statistics). Expected costs for a single UTI were estimated according to data published in the medical literature. RESULTS: On average, there were 1.87 UTI on intensive care units (ICU) and 0.81 UTI on peripheral wards per 1,000 patient days; 4.5% of the annual 146.1 million patient days in German hospitals were contributed by ICUs. In total, there are approximately 155,000 nosocomial UTI every year. Each UTI leads to costs of about 1,000 euros; 20% of all nosocomial infections are preventable. CONCLUSIONS: Just for nosocomial UTI, appropriate infection control measures may reduce the annual health care costs by 14,500 euros for every German hospital.


Assuntos
Infecção Hospitalar/economia , Infecção Hospitalar/epidemiologia , Custos de Cuidados de Saúde/estatística & dados numéricos , Sistema de Registros , Infecções Urinárias/economia , Infecções Urinárias/epidemiologia , Alemanha/epidemiologia , Humanos , Vigilância da População , Prevalência
10.
J Hosp Infect ; 65(4): 348-53, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17350731

RESUMO

A total closure of an affected medical department is one of the most expensive infection control measures during investigation of a nosocomial outbreak. However, until now there has been no systematic analysis of typical characteristics of outbreaks, for which closure was considered necessary. This article presents data on features of such nosocomial epidemics published during the past 40 years in the medical literature. A search of the Outbreak Database (1561 nosocomial outbreaks in file) revealed a total of 194 outbreaks that ended up with some kind of closure of the unit (median closure time: 14 days). Closure rates (CRs) were calculated and stratified for medical departments, for causative pathogens, for outbreak sources, and for the assumed mode of transmission. Data were then compared to the overall average CR of 12.4% in the entire database. Wards in geriatric patient care were closed significantly more frequently (CR: 30.3%; P<0.001) whereas paediatric wards showed a significantly lower CR (6.1%; P=0.03). Pathogen species with the highest CR were norovirus (44.1%; P<0.001) and influenza/parainfluenza virus (38.5%; P<0.001). If patients were the source of the outbreak, the CR was significantly increased (16.7%; P=0.03). Infections of the central nervous system were most often associated with closure of the ward (24.2%; P=001). A systematic evaluation of nosocomial outbreaks can be a valuable tool for education of staff in the absence of an outbreak, but may be even more helpful for potentially cost-intensive decisions in the acute outbreak setting on the ward.


Assuntos
Infecção Hospitalar/epidemiologia , Surtos de Doenças/estatística & dados numéricos , Fechamento de Instituições de Saúde/estatística & dados numéricos , Unidades Hospitalares/estatística & dados numéricos , Controle de Infecções/métodos , Infecção Hospitalar/classificação , Infecção Hospitalar/prevenção & controle , Bases de Dados Factuais , Fechamento de Instituições de Saúde/economia , Humanos
13.
J Hosp Infect ; 65(1): 15-23, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17145102

RESUMO

Drug-related outbreaks are frequently reported from various medical departments. A systematic review was performed to describe characteristics of these outbreaks and to determine the most frequent occasions in which contamination of substances for patient care take place. Articles were assessed by a search of the outbreak database, a search of PubMed, and hand search of reference lists from relevant articles. Articles published before 1990 were excluded. Data on affected patients, hospital-acquired infections, substances, pathogens and graded information about the location of the contamination incidence were extracted. A total of 2250 patients in 128 articles were included, mostly from intensive care units or haematological departments. Septicaemia was the most frequent hospital-acquired infection. Most often articles report contamination of blood products and heparin-sodium chloride solutions. The most frequent pathogens were hepatitis A virus, Yersinia enterocolitica, and Serratia spp. for blood products and Burkholderia cepacia and Enterobacter spp. for substances other than blood products. Mortality was highest if red blood cells or total parenteral nutrition formulas were contaminated. In 64 of the outbreaks multi-dose vials had been used against the manufacturers' recommendations. Thus, drug-related outbreaks are likely to occur particularly when basic hygiene measures are disobeyed. A large proportion of drug-related nosocomial infections could have been prevented, for example, by avoiding the use of multi-dose vials.


Assuntos
Transfusão de Componentes Sanguíneos/efeitos adversos , Infecção Hospitalar/etiologia , Surtos de Doenças/estatística & dados numéricos , Contaminação de Medicamentos/estatística & dados numéricos , Infecção Hospitalar/mortalidade , Infecção Hospitalar/prevenção & controle , Contaminação de Medicamentos/prevenção & controle , Humanos , Controle de Infecções/estatística & dados numéricos , Nutrição Parenteral Total/efeitos adversos
14.
Anaesthesist ; 56(2): 151-7, 2007 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-17171367

RESUMO

The incidence of vancomycin-resistant enterococci (VRE), especially E. faecium, is increasing in several German hospitals and some facilities have experienced VRE outbreaks. The German National Nosocomial Infection Surveillance System has also noticed a sharp increase in the incidence of nosocomial VRE infections per 10,000 patients from 0.5 in 2003 to 11.0 in 2005 accompanied by a rise in VRE-associated mortality. However, the reasons of this increase remain unknown. As VRE may cause severe nosocomial infections, transmission must be restricted. This article provides the guidelines as defined by the workshop of the German Society for Hygiene and Microbiology for the prevention of VRE transmission in both, endemic and epidemic, settings. The following topics are discussed: indication for VRE screening, microbiological diagnostics, general infection control measures (isolation precautions and use of protective clothing) and additional hygiene measures in the nosocomial VRE outbreak setting.


Assuntos
Enterococcus faecium/efeitos dos fármacos , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Infecções por Bactérias Gram-Positivas/microbiologia , Resistência a Vancomicina , Infecção Hospitalar/tratamento farmacológico , Infecção Hospitalar/microbiologia , Infecção Hospitalar/prevenção & controle , Alemanha/epidemiologia , Infecções por Bactérias Gram-Positivas/prevenção & controle , Humanos , Fatores de Risco
15.
J Hosp Infect ; 64(2): 156-61, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16899325

RESUMO

Since 1997, the Krankenhaus Infektions Surveillance System (KISS) has collected data on surgical site infections (SSIs) following Caesarean delivery (CD). The aim of this study was to determine whether surveillance and feedback of healthcare-associated infections (HAIs) could reduce the infection rate after CD. Only departments that had participated in KISS for at least three years were included in the analysis. The CD infection rates of the first, second and third years of KISS participation were compared for significant differences. The relative risk was calculated for the first and the third year of KISS participation. Multi-variate logistic regression analysis was performed to detect significant risk factors for SSI after CD using the third year of participation as one parameter. Twenty-six of 52 obstetric and gynaecology departments met the study's inclusion criteria. In those 26 departments, 17,405 CD procedures were performed and 331 SSIs were recorded (1.9%). The SSI rate after CD procedures was significantly reduced in the third year of KISS participation (1.6%) compared with the first year of KISS participation (2.4%), with a relative risk of 0.63 [95% confidence interval (CI) 0.48-0.82]. Logistic regression analysis confirmed that KISS participation over three years was an independent factor for the reduction of SSI rate (odds ratio 0.64; 95% CI 0.49-0.83). As shown previously for other types of HAI, this study demonstrated that continuous surveillance and comparison with stratified reference data could reduce SSI infection rates after CD.


Assuntos
Cesárea , Infecção Hospitalar/prevenção & controle , Controle de Infecções , Avaliação de Resultados em Cuidados de Saúde , Vigilância de Evento Sentinela , Infecção da Ferida Cirúrgica/prevenção & controle , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/etiologia , Feminino , Alemanha/epidemiologia , Humanos , Controle de Infecções/métodos , Gravidez , Infecção da Ferida Cirúrgica/epidemiologia , Infecção da Ferida Cirúrgica/etiologia
16.
J Hosp Infect ; 63(3): 246-54, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16713019

RESUMO

Nosocomial aspergillosis represents a serious threat for severely immunocompromised patients and numerous outbreaks of invasive aspergillosis have been described. This systematic review summarizes characteristics and mortality rates of infected patients, distribution of Aspergillus spp. in clinical specimens, concentrations of aspergillus spores in volumetric air samples, and outbreak sources. A web-based register of nosocomial epidemics (outbreak database), PubMed and reference lists of relevant articles were searched systematically for descriptions of aspergillus outbreaks in hospital settings. Fifty-three studies with a total of 458 patients were included. In 356 patients, the lower respiratory tract was the primary site of aspergillus infection. Species identified most often were Aspergillus fumigatus (154 patients) and Aspergillus flavus (101 patients). Haematological malignancies were the predominant underlying diseases (299 individuals). The overall fatality rate in these 299 patients (57.6%) was significantly greater than that in patients without severe immunodeficiency (39.4% of 38 individuals). Construction or demolition work was often (49.1%) considered to be the probable or possible source of the outbreak. Even concentrations of Aspergillus spp. below 1 colony-forming unit/m(3) were sufficient to cause infection in high-risk patients. Virtually all outbreaks of nosocomial aspergillosis are attributed to airborne sources, usually construction. Even small concentrations of spores have been associated with outbreaks, mainly due to A. fumigatus or A. flavus. Patients at risk should not be exposed to aspergilli.


Assuntos
Aspergilose/epidemiologia , Aspergillus flavus/patogenicidade , Aspergillus fumigatus/patogenicidade , Infecção Hospitalar/epidemiologia , Surtos de Doenças/estatística & dados numéricos , Esporos Fúngicos/patogenicidade , Poluentes Atmosféricos/isolamento & purificação , Aspergilose/mortalidade , Aspergilose/prevenção & controle , Aspergillus flavus/isolamento & purificação , Aspergillus flavus/fisiologia , Aspergillus fumigatus/isolamento & purificação , Aspergillus fumigatus/fisiologia , Materiais de Construção/microbiologia , Infecção Hospitalar/mortalidade , Infecção Hospitalar/prevenção & controle , Humanos , Esporos Fúngicos/isolamento & purificação
17.
Anaesthesist ; 55(7): 778-83, 2006 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-16570167

RESUMO

In Germany, methicillin-resistant S. aureus (MRSA) is increasing continuously. To control the spread of MRSA, active surveillance and admission screening are recommended. In most cases, screening cultures of patients at risk for MRSA will be sufficient. Screening of all patients admitted to an ICU is cost-effective when the incidence of MRSA and nosocomial MRSA infections is high (>2 cases/100 patients and 0.3 MRSA infections/100 patients, respectively): Under these circumstances, a decrease in the incidence of nosocomial MRSA infections of 50% leads to cost-effectiveness at costs of 16 Euro/sample (including subsequent costs). If the incidence of nosocomial MRSA infections decreases by 75%, costs of 24 Euro/sample (including subsequent costs) are cost-effective. If the incidence of MRSA is high, screening by PCR may be cost-effective for patients at high risk for MRSA, especially if they are isolated prophylactically. Recently, PCR methods have been developed which allow the specific identification of MRSA even from nasal swabs.


Assuntos
Infecção Hospitalar/diagnóstico , Infecção Hospitalar/prevenção & controle , Resistência a Meticilina , Infecções Estafilocócicas/diagnóstico , Infecções Estafilocócicas/prevenção & controle , Staphylococcus aureus/efeitos dos fármacos , Análise Custo-Benefício , Cuidados Críticos , Infecção Hospitalar/microbiologia , Humanos , Infecções Estafilocócicas/microbiologia
18.
Clin Exp Med ; 5(4): 177-83, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16362797

RESUMO

Respiratory syncytial virus (RSV) may play an important role in allergic diathesis by creating a Th2-type immune response. Mycobacterium bovis bacillus Calmette-Guérin (BCG) is known to induce a Th1-type immune response, but the association of BCG vaccination and the suppression of allergy development remain controversial. We investigated the influence of BCG vaccination on the immune response to RSV in a mouse model. Balb/c mice were BCG vaccinated, RSV infected and ovalbumin (OVA) challenged. Mice were sacrificed one, two and four weeks after allergen exposure. Bronchoalveolar lavage was performed. Alveolar macrophages and lymphocytes from spleens and lung-associated lymph nodes were investigated for cytokine production and cell proliferation. Serum was tested for allergen-specific immunoglobulin-E (IgE). Lung eosinophilia was diminished by BCG immunisation. OVA-specific serum IgE was increased regardless of prior BCG vaccination. Interleukin-4 secretion of spleen lymphocytes increased in BCG-vaccinated mice only one week after allergen exposure but was comparable to non-vaccinated mice at four weeks. The reactivity of spleen lymphocytes towards concanavalin-A to secrete interferon-gamma was increased in the vaccinated group at the end of the observation period. Interleukin-6 and tumour necrosis factor-alpha secretion of alveolar macrophages as well as proliferation of stimulated thoracic lymph node cells were increased and prolonged in vaccinated mice. BCG immunisation led to a local suppression of the allergic reaction within the lung. No reduction of systemic IgE production was observed. Further studies are necessary to determine a possible time dependence of BCG immunisation.


Assuntos
Alérgenos/administração & dosagem , Vacina BCG/imunologia , Mycobacterium bovis/imunologia , Ovalbumina/administração & dosagem , Infecções por Vírus Respiratório Sincicial/imunologia , Animais , Líquido da Lavagem Broncoalveolar , Células Cultivadas , Feminino , Imunoglobulina E/sangue , Exposição por Inalação , Linfonodos/imunologia , Linfócitos/imunologia , Macrófagos Alveolares/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Tamanho do Órgão , Baço/citologia , Baço/imunologia
19.
Artigo em Alemão | MEDLINE | ID: mdl-16078155

RESUMO

Several reasons such as ignorance, convenience, or economical considerations might lead to disobeying basic hygiene measures in anaesthesia. The most important recommendations are for: 1. General anaesthesia: bacterial filters prevent breathing circuit contamination from patient's expiratory secretions. This way reprocessing of reusable components is required only once a day or in case an external contamination has occurred; 2. Neuraxial blockade: use of sterile gloves, a surgical face mask, and a sterile gown is recommended; 3. Intravenous anaesthesia: equipment not manufactured for re-use may not be used for more than one patient under any circumstances. One-way-valves do not securely prevent retrograde contamination of the infusion system. Do not use multi dose vials unless declared by manufacturer. Alcoholic hand disinfection is the most important measure in order to avoid nosocomial pathogen transmission and infection.


Assuntos
Anestesia/normas , Infecção Hospitalar/prevenção & controle , Controle de Infecções , Anestesia por Condução/instrumentação , Anestesia por Condução/normas , Anestesia por Inalação/instrumentação , Anestesia por Inalação/normas , Anestesia Intravenosa/instrumentação , Anestesia Intravenosa/normas , Filtração , Humanos , Higiene/normas , Esterilização
20.
Anaesthesist ; 54(10): 975-8, 980-2, 2005 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-15999265

RESUMO

BACKGROUND: Aim of this study was to determine to what extent evidence-based infection control recommendations are applied in German intensive care units (ICUs). METHODS: A questionnaire concerning handling of tubes, central vascular catheters (CVC), urinary tract catheters and methicillin-resistant Staphylococcus aureus (MRSA) positive patients was sent to 230 participants of the German Nosocomial Infection Surveillance System (KISS). RESULTS: Nasal intubation is routinely performed in 9% of ICUs, all recommended measures for CVC insertion were obeyed by 43% of ICUs and one-third of ICUs conduct regular screening of urine in catheterized patients. Urinary tract catheters are replaced at defined time intervals in 37% of ICUs. MRSA positive patients are not isolated in 5% of ICUs. MRSA screening on admission is not performed for high risk patients in 16% of ICUs. CONCLUSIONS: There are still many German ICUs in which evidence-based recommendations are not implemented. Training of staff is necessary to improve quality of patient care.


Assuntos
Infecção Hospitalar/prevenção & controle , Controle de Infecções/métodos , Unidades de Terapia Intensiva/normas , Cateterismo Venoso Central , Coleta de Dados , Medicina Baseada em Evidências , Alemanha , Guias como Assunto , Humanos , Intubação Gastrointestinal , Resistência a Meticilina , Infecções Estafilocócicas/microbiologia , Infecções Estafilocócicas/prevenção & controle , Staphylococcus aureus/efeitos dos fármacos , Inquéritos e Questionários , Cateterismo Urinário
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA